首页 > 最新文献

Cancer Epidemiology最新文献

英文 中文
Early-life tobacco exposure, genetic susceptibility and incident colorectal cancer risk in UK biobank: A prospective cohort analysis 英国生物样本库中的早期烟草暴露、遗传易感性和结直肠癌风险:一项前瞻性队列分析
IF 2.3 3区 医学 Q3 ONCOLOGY Pub Date : 2026-01-03 DOI: 10.1016/j.canep.2025.102985
Yu Long , Yuting Zhu , Meiyin Lin , Qinming Li , Jun Liang , Chunyang Wang , Ruijie Zeng , Dongling Luo , Lijun Zhang , Yuyin Ma , Chongyang Duan , Yue Zhu , Hao Chen , Jianhua Liu

Background

Although tobacco exposure is an established risk factor for colorectal cancer (CRC), the specific impact of early-life exposure (from prenatal to adolescence) and its joints with genetic susceptibility remains uncertain. This population-based study aimed to investigate the joint effects of early-life tobacco exposure and polygenic risk on CRC.

Methods

Data from UK Biobank participants were analyzed to assess tobacco exposure during two periods: prenatal exposure (n = 429,847) and age of smoking initiation (n = 430,672). Using Cox proportional hazards models, the associations between early-life tobacco exposure and CRC incidence were explored. Additionally, we evaluated the mediating role of accelerated biological aging in the link between early-life tobacco exposure and CRC, and further integrated the polygenic risk score (PRS) to assess the joint effects of genetic on CRC risk.

Results

Early-life tobacco exposure exhibited age-at-initiation-dependent CRC risk associations. Smoking initiation in adolescence [hazard ratios (HR) = 1.13, 95 % confidence intervals (CI): 1.06–1.22], and adulthood (HR = 1.19, 95 % CI: 1.10–1.30) all significantly increased risk (P < 0.001), while in utero exposure and smoking initiation childhood (HR:1.06, 95 % CI: 0.94–1.19, P = 0.372) showed a suggestive but non-significant trend (HR:1.05, 95 % CI: 1.00–1.11, P = 0.066). In the joint analysis, high-PRS individuals with prenatal tobacco exposure had an elevated CRC risk compared to those with low PRS and no exposure (HR 1.28, 95 % CI: 1.16–1.42, P < 0.001). Furthermore, among high-PRS individuals, smoking initiation at any age (childhood, adolescence, or adulthood) increased CRC risk relative to never-smokers with low PRS. Mediation analysis indicated that accelerated biological aging may contribute to the association between smoking initiation at different ages and increased CRC risk.

Conclusion

Early-life tobacco exposure elevated CRC risk, especially in genetically susceptible individuals. These findings underscored the importance of early tobacco prevention and enhanced screening for high genetic-risk populations.
背景虽然烟草暴露是结直肠癌(CRC)的一个确定的危险因素,但早期生活暴露(从产前到青春期)及其关节与遗传易感性的具体影响仍不确定。这项以人群为基础的研究旨在探讨早期烟草暴露和多基因风险对结直肠癌的共同影响。方法分析来自英国生物银行参与者的数据,评估两个时期的烟草暴露情况:产前暴露(n = 429,847)和开始吸烟年龄(n = 430,672)。采用Cox比例风险模型,探讨早期吸烟与结直肠癌发病率之间的关系。此外,我们评估了加速生物衰老在早期烟草暴露与结直肠癌之间的中介作用,并进一步整合多基因风险评分(PRS)来评估遗传对结直肠癌风险的共同影响。结果早期烟草暴露表现出年龄依赖性结直肠癌风险关联。吸烟开始在青春期(危害比(人力资源)= 1.13,95 % (CI)置信区间:1.06 - -1.22),和成年(HR = 1.19, 95 % CI: 1.10 - -1.30)所有风险显著增加(P & lt; 0.001),而在子宫内暴露和吸烟开始的童年(人力资源:1.06,95 % CI: 0.94 - -1.19, P = 0.372)显示暗示但非重大的趋势(人力资源:1.05,95 % CI: 1.00 - -1.11, P = 0.066)。在联合分析中,产前烟草暴露的高PRS个体与低PRS和无烟草暴露的个体相比,CRC风险升高(HR 1.28, 95 % CI: 1.16-1.42, P <; 0.001)。此外,在高PRS个体中,任何年龄(儿童、青少年或成年)开始吸烟都比低PRS从不吸烟者增加结直肠癌风险。中介分析表明,加速的生物老化可能有助于不同年龄开始吸烟与CRC风险增加之间的关联。结论早期接触烟草会增加结直肠癌的风险,尤其是在遗传易感人群中。这些发现强调了早期预防烟草和加强对高遗传风险人群筛查的重要性。
{"title":"Early-life tobacco exposure, genetic susceptibility and incident colorectal cancer risk in UK biobank: A prospective cohort analysis","authors":"Yu Long ,&nbsp;Yuting Zhu ,&nbsp;Meiyin Lin ,&nbsp;Qinming Li ,&nbsp;Jun Liang ,&nbsp;Chunyang Wang ,&nbsp;Ruijie Zeng ,&nbsp;Dongling Luo ,&nbsp;Lijun Zhang ,&nbsp;Yuyin Ma ,&nbsp;Chongyang Duan ,&nbsp;Yue Zhu ,&nbsp;Hao Chen ,&nbsp;Jianhua Liu","doi":"10.1016/j.canep.2025.102985","DOIUrl":"10.1016/j.canep.2025.102985","url":null,"abstract":"<div><h3>Background</h3><div>Although tobacco exposure is an established risk factor for colorectal cancer (CRC), the specific impact of early-life exposure (from prenatal to adolescence) and its joints with genetic susceptibility remains uncertain. This population-based study aimed to investigate the joint effects of early-life tobacco exposure and polygenic risk on CRC.</div></div><div><h3>Methods</h3><div>Data from UK Biobank participants were analyzed to assess tobacco exposure during two periods: prenatal exposure (n = 429,847) and age of smoking initiation (n = 430,672). Using Cox proportional hazards models, the associations between early-life tobacco exposure and CRC incidence were explored. Additionally, we evaluated the mediating role of accelerated biological aging in the link between early-life tobacco exposure and CRC, and further integrated the polygenic risk score (PRS) to assess the joint effects of genetic on CRC risk.</div></div><div><h3>Results</h3><div>Early-life tobacco exposure exhibited age-at-initiation-dependent CRC risk associations. Smoking initiation in adolescence [hazard ratios (HR) = 1.13, 95 % confidence intervals (CI): 1.06–1.22], and adulthood (HR = 1.19, 95 % CI: 1.10–1.30) all significantly increased risk (<em>P</em> &lt; 0.001), while in utero exposure and smoking initiation childhood (HR:1.06, 95 % CI: 0.94–1.19, <em>P</em> = 0.372) showed a suggestive but non-significant trend (HR:1.05, 95 % CI: 1.00–1.11, <em>P</em> = 0.066). In the joint analysis, high-PRS individuals with prenatal tobacco exposure had an elevated CRC risk compared to those with low PRS and no exposure (HR 1.28, 95 % CI: 1.16–1.42, P &lt; 0.001). Furthermore, among high-PRS individuals, smoking initiation at any age (childhood, adolescence, or adulthood) increased CRC risk relative to never-smokers with low PRS. Mediation analysis indicated that accelerated biological aging may contribute to the association between smoking initiation at different ages and increased CRC risk.</div></div><div><h3>Conclusion</h3><div>Early-life tobacco exposure elevated CRC risk, especially in genetically susceptible individuals. These findings underscored the importance of early tobacco prevention and enhanced screening for high genetic-risk populations.</div></div>","PeriodicalId":56322,"journal":{"name":"Cancer Epidemiology","volume":"100 ","pages":"Article 102985"},"PeriodicalIF":2.3,"publicationDate":"2026-01-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145883748","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Factors associated with long COVID among cancer survivors: A population-based analysis 癌症幸存者中与长COVID相关的因素:一项基于人群的分析
IF 2.3 3区 医学 Q3 ONCOLOGY Pub Date : 2026-01-03 DOI: 10.1016/j.canep.2025.102984
Stuart J. Case , Lindsay Sabik , Haley Grant

Introduction

Cancer survivors endure unique immune system suppression as a result of their cancer treatment, potentially making them susceptible to long COVID in ways that differ from the general population. The purpose of this study is to assess what factors are associated with long COVID among cancer survivors.

Methods

Observational, cross-sectional data from the 2023 Behavioral Risk Factor Surveillance System (BRFSS) survey were analyzed. The main outcome of interest was the prevalence of long COVID among cancer survivors who had tested positive for COVID-19. Bivariate analyses were conducted comparing those who did and did not have long COVID, and logistic regression models were used to determine the sociodemographic variables and individual health factors associated with long COVID among cancer survivors.

Results

In this sample, 15.2 % of cancer survivors who had tested positive for COVID-19 indicated they had long COVID. Cancer survivors who were male, older, received flu and COVID-19 vaccinations, and did not have diabetes or asthma had significantly lower odds of having long COVID.

Conclusion

This study provides insight into what sociodemographic and health-related factors are associated with the presence of long COVID, including age, sex, vaccination status, and comorbid conditions. Future longitudinal studies are warranted to establish causal patterns.
由于癌症治疗,癌症幸存者承受着独特的免疫系统抑制,这可能使他们以与普通人群不同的方式容易感染COVID。本研究的目的是评估哪些因素与癌症幸存者的长COVID相关。方法对2023年行为危险因素监测系统(BRFSS)调查的观察性横断面数据进行分析。主要研究结果是COVID-19检测呈阳性的癌症幸存者中长冠状病毒的患病率。进行双变量分析,比较有和没有长COVID的患者,并使用逻辑回归模型确定与癌症幸存者中长COVID相关的社会人口学变量和个人健康因素。结果在该样本中,15.2% %的COVID-19检测阳性的癌症幸存者表示他们长期患有COVID。男性、年龄较大、接种过流感和COVID-19疫苗、没有糖尿病或哮喘的癌症幸存者患COVID-19的几率明显较低。结论本研究提供了与长COVID存在相关的社会人口统计学和健康相关因素,包括年龄、性别、疫苗接种状况和合并症。未来的纵向研究有必要建立因果模式。
{"title":"Factors associated with long COVID among cancer survivors: A population-based analysis","authors":"Stuart J. Case ,&nbsp;Lindsay Sabik ,&nbsp;Haley Grant","doi":"10.1016/j.canep.2025.102984","DOIUrl":"10.1016/j.canep.2025.102984","url":null,"abstract":"<div><h3>Introduction</h3><div>Cancer survivors endure unique immune system suppression as a result of their cancer treatment, potentially making them susceptible to long COVID in ways that differ from the general population. The purpose of this study is to assess what factors are associated with long COVID among cancer survivors.</div></div><div><h3>Methods</h3><div>Observational, cross-sectional data from the 2023 Behavioral Risk Factor Surveillance System (BRFSS) survey were analyzed. The main outcome of interest was the prevalence of long COVID among cancer survivors who had tested positive for COVID-19. Bivariate analyses were conducted comparing those who did and did not have long COVID, and logistic regression models were used to determine the sociodemographic variables and individual health factors associated with long COVID among cancer survivors.</div></div><div><h3>Results</h3><div>In this sample, 15.2 % of cancer survivors who had tested positive for COVID-19 indicated they had long COVID. Cancer survivors who were male, older, received flu and COVID-19 vaccinations, and did not have diabetes or asthma had significantly lower odds of having long COVID.</div></div><div><h3>Conclusion</h3><div>This study provides insight into what sociodemographic and health-related factors are associated with the presence of long COVID, including age, sex, vaccination status, and comorbid conditions. Future longitudinal studies are warranted to establish causal patterns.</div></div>","PeriodicalId":56322,"journal":{"name":"Cancer Epidemiology","volume":"100 ","pages":"Article 102984"},"PeriodicalIF":2.3,"publicationDate":"2026-01-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145883747","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effect of metformin exposure on colorectal cancer incidence according to tumor sidedness 二甲双胍暴露对结直肠癌发病率的影响
IF 2.3 3区 医学 Q3 ONCOLOGY Pub Date : 2025-12-27 DOI: 10.1016/j.canep.2025.102983
Yehudit Peerless , Gal Strauss , Ofer Margalit , Einat Shacham-Shmueli , Yu-Xiao Yang , Ben Boursi

Background

Colorectal cancer (CRC) is a major cause of cancer-related morbidity and mortality. Tumor sidedness influences treatment decisions for metastatic disease due to differences in biology and therapeutic response. Metformin, an anti-diabetic medication, may reduce CRC risk. This study aims to evaluate the relationship between metformin exposure and CRC risk based on tumor-sidedness.

Methods

A nested case-control study was conducted using the Veterans Administration (VA) database (1999–2020). The cohort included individuals with diabetes mellitus and at least 3 years of follow-up. CRC cases were identified and classified by tumor sidedness. Controls were selected via incidence-density sampling, matched on age, sex, index-date, and first VA encounter. Exposure of interest was cumulative metformin use prior to the index-date. Conditional logistic regression was used to estimate adjusted odds-ratios (ORs) and 95 % confidence intervals (CIs). The analysis was adjusted for race, BMI, smoking, aspirin, statins, and other anti-diabetic medications.

Results

The study included 31,078 CRC cases and 310,621 matched controls among diabetic individuals. Metformin exposure showed no effect on right-sided CRC incidence (adjusted OR 1.03, 95 %CI 0.92–1.16 for 1–3 years; 0.96, 95 %CI 0.83–1.12 for 3–5 years). In contrast, in patients with left-sided CRC metformin use was associated with a reduced risk of CRC (adjusted OR 0.90, 95 %CI 0.82–0.98 for 1–3 years; 0.87, 95 %CI 0.77–0.98 for 3–5 years).

Conclusions

Metformin was associated with a decrease in the incidence of left-sided CRC. These results suggest the influence of tumor sidedness, not only on treatment effect, but on prevention strategies as well.
结直肠癌(CRC)是癌症相关发病率和死亡率的主要原因。由于生物学和治疗反应的差异,肿瘤的侧边性影响转移性疾病的治疗决策。二甲双胍是一种抗糖尿病药物,可以降低结直肠癌的风险。本研究旨在基于肿瘤侧性评估二甲双胍暴露与结直肠癌风险之间的关系。方法采用巢式病例对照研究,采用退伍军人管理局(VA)数据库(1999-2020)。该队列包括糖尿病患者和至少3年的随访。根据肿瘤的侧边性对结直肠癌病例进行鉴别和分类。通过发病率-密度抽样选择对照,并根据年龄、性别、索引日期和首次遇VA进行匹配。感兴趣的暴露是在索引日期之前累积使用二甲双胍。使用条件逻辑回归估计调整比值比(ORs)和95% %置信区间(ci)。该分析对种族、BMI、吸烟、阿司匹林、他汀类药物和其他抗糖尿病药物进行了调整。结果该研究包括31,078例结直肠癌病例和310,621例匹配的糖尿病对照。二甲双胍暴露对右侧结直肠癌发病率没有影响(1-3年调整OR 1.03, 95 %CI 0.92-1.16; 3-5年调整OR 0.96, 95 %CI 0.83-1.12)。相反,在左侧结直肠癌患者中,使用二甲双胍与结直肠癌风险降低相关(调整后的OR为0.90,95 %CI 0.82-0.98,持续1-3年;0.87,95 %CI 0.77-0.98,持续3-5年)。结论:二甲双胍可降低左侧结直肠癌的发病率。这些结果表明,肿瘤的侧边性不仅影响治疗效果,而且影响预防策略。
{"title":"The effect of metformin exposure on colorectal cancer incidence according to tumor sidedness","authors":"Yehudit Peerless ,&nbsp;Gal Strauss ,&nbsp;Ofer Margalit ,&nbsp;Einat Shacham-Shmueli ,&nbsp;Yu-Xiao Yang ,&nbsp;Ben Boursi","doi":"10.1016/j.canep.2025.102983","DOIUrl":"10.1016/j.canep.2025.102983","url":null,"abstract":"<div><h3>Background</h3><div>Colorectal cancer (CRC) is a major cause of cancer-related morbidity and mortality. Tumor sidedness influences treatment decisions for metastatic disease due to differences in biology and therapeutic response. Metformin, an anti-diabetic medication, may reduce CRC risk. This study aims to evaluate the relationship between metformin exposure and CRC risk based on tumor-sidedness.</div></div><div><h3>Methods</h3><div>A nested case-control study was conducted using the Veterans Administration (VA) database (1999–2020). The cohort included individuals with diabetes mellitus and at least 3 years of follow-up. CRC cases were identified and classified by tumor sidedness. Controls were selected via incidence-density sampling, matched on age, sex, index-date, and first VA encounter. Exposure of interest was cumulative metformin use prior to the index-date. Conditional logistic regression was used to estimate adjusted odds-ratios (ORs) and 95 % confidence intervals (CIs). The analysis was adjusted for race, BMI, smoking, aspirin, statins, and other anti-diabetic medications.</div></div><div><h3>Results</h3><div>The study included 31,078 CRC cases and 310,621 matched controls among diabetic individuals. Metformin exposure showed no effect on right-sided CRC incidence (adjusted OR 1.03, 95 %CI 0.92–1.16 for 1–3 years; 0.96, 95 %CI 0.83–1.12 for 3–5 years). In contrast, in patients with left-sided CRC metformin use was associated with a reduced risk of CRC (adjusted OR 0.90, 95 %CI 0.82–0.98 for 1–3 years; 0.87, 95 %CI 0.77–0.98 for 3–5 years).</div></div><div><h3>Conclusions</h3><div>Metformin was associated with a decrease in the incidence of left-sided CRC. These results suggest the influence of tumor sidedness, not only on treatment effect, but on prevention strategies as well.</div></div>","PeriodicalId":56322,"journal":{"name":"Cancer Epidemiology","volume":"100 ","pages":"Article 102983"},"PeriodicalIF":2.3,"publicationDate":"2025-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145839684","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Liver and gastric cancer incidence and mortality in Non‐Western immigrant men and women: a register-based cohort study from 2000 to 2017 非西方移民男性和女性的肝癌和胃癌发病率和死亡率:2000年至2017年的一项基于登记的队列研究
IF 2.3 3区 医学 Q3 ONCOLOGY Pub Date : 2025-12-24 DOI: 10.1016/j.canep.2025.102974
Angeza Abdul Khaliq , Maarit H. Lamminmäki , Sirpa H. Heinävaara , Tytti M. Sarkeala

Introduction

Geographical variations in health reflect differences in environments, lifestyles, and healthcare access. Notably, non-Western countries exhibit higher rates of infection-related cancers such as liver and gastric cancers, compared to Western countries. This study compares sex-specific incidence and mortality of liver and gastric cancers in non-Western immigrants with those of the native Finnish population. We also assess how region of birth, age at immigration, and duration of residence influence liver and gastric cancer incidence and mortality among non-Western population.

Material and method

We analysed data from 162,844 non-Western immigrant men and 161,090 women residing in Finland from 1973 to 2017. Liver and gastric cancer diagnoses and causes of death from 2000 to 2017 were linked from national registries. We assessed cancer risks using a multivariate Poisson regression model, adjusting for age group, calendar period, and region of birth.

Results

Non-Western immigrant men had higher liver cancer incidence (Relative risk (IRR) 1.41, 95 % Confidence Interval (CI) 1.13–1.78) and mortality (MRR 1.50, CI 1.16–1.94), and higher gastric cancer incidence (IRR 1.74, CI 1.46–2.06) and mortality (MRR 1.74, CI 1.42–2.14) than native men. Among non-Western immigrant women, only gastric cancer showed increased incidence (IRR 2.21, 95 % CI 1.88–2.60) and mortality (MRR 2.22, 95 % CI 1.83–2.70). Age at immigration did not impact risk levels.Prolonged duration of residence decreased the risk of gastric cancer in non-Western women, whereas in men the risk remained elevated.

Discussion

The increased cancer risk among non-Western immigrants may stem from greater exposure to infections such as hepatitis B and C and H. pylori, prevalent in their countries of origin. Cultural adaptation and lifestyle changes, particularly in alcohol and tobacco use, also play a role.

Conclusion

Targeted healthcare measures, including early diagnosis and lifestyle interventions, are crucial for reducing cancer risks among non-Western immigrants in Finland. Addressing language and cultural barriers is essential for effective healthcare and for reducing health disparities.
导言:健康的地理差异反映了环境、生活方式和医疗保健获取的差异。值得注意的是,与西方国家相比,非西方国家的肝癌和胃癌等与感染有关的癌症发病率更高。本研究比较了非西方移民与芬兰本土人口中肝癌和胃癌的性别特异性发病率和死亡率。我们还评估了出生地区、移民年龄和居住时间对非西方人群中肝癌和胃癌发病率和死亡率的影响。材料和方法:我们分析了1973年至2017年居住在芬兰的162,844名非西方移民男性和161,090名女性的数据。从2000年到2017年,肝癌和胃癌的诊断和死亡原因与国家登记处相关联。我们使用多元泊松回归模型评估癌症风险,调整了年龄组、日历期和出生地区。结果:非西方移民男性的肝癌发病率(相对危险度(IRR) 1.41, 95 %置信区间(CI) 1.13-1.78)和死亡率(MRR 1.50, CI 1.16-1.94)高于本土男性,胃癌发病率(IRR 1.74, CI 1.46-2.06)和死亡率(MRR 1.74, CI 1.42-2.14)高于本土男性。在非西方移民妇女中,只有胃癌的发病率(IRR 2.21, 95 % CI 1.88-2.60)和死亡率(MRR 2.22, 95 % CI 1.83-2.70)增加。移民年龄对风险水平没有影响。居住时间的延长降低了非西方女性患胃癌的风险,而男性患胃癌的风险仍然升高。讨论:非西方移民癌症风险的增加可能源于更多的感染,如乙肝、丙肝和幽门螺杆菌,在他们的原籍国流行。文化适应和生活方式的改变,特别是在使用酒精和烟草方面,也发挥了作用。结论:有针对性的医疗保健措施,包括早期诊断和生活方式干预,对于降低芬兰非西方移民的癌症风险至关重要。消除语言和文化障碍对于有效的医疗保健和减少健康差距至关重要。
{"title":"Liver and gastric cancer incidence and mortality in Non‐Western immigrant men and women: a register-based cohort study from 2000 to 2017","authors":"Angeza Abdul Khaliq ,&nbsp;Maarit H. Lamminmäki ,&nbsp;Sirpa H. Heinävaara ,&nbsp;Tytti M. Sarkeala","doi":"10.1016/j.canep.2025.102974","DOIUrl":"10.1016/j.canep.2025.102974","url":null,"abstract":"<div><h3>Introduction</h3><div>Geographical variations in health reflect differences in environments, lifestyles, and healthcare access. Notably, non-Western countries exhibit higher rates of infection-related cancers such as liver and gastric cancers, compared to Western countries. This study compares sex-specific incidence and mortality of liver and gastric cancers in non-Western immigrants with those of the native Finnish population. We also assess how region of birth, age at immigration, and duration of residence influence liver and gastric cancer incidence and mortality among non-Western population.</div></div><div><h3>Material and method</h3><div>We analysed data from 162,844 non-Western immigrant men and 161,090 women residing in Finland from 1973 to 2017. Liver and gastric cancer diagnoses and causes of death from 2000 to 2017 were linked from national registries. We assessed cancer risks using a multivariate Poisson regression model, adjusting for age group, calendar period, and region of birth.</div></div><div><h3>Results</h3><div>Non-Western immigrant men had higher liver cancer incidence (Relative risk (IRR) 1.41, 95 % Confidence Interval (CI) 1.13–1.78) and mortality (MRR 1.50, CI 1.16–1.94), and higher gastric cancer incidence (IRR 1.74, CI 1.46–2.06) and mortality (MRR 1.74, CI 1.42–2.14) than native men. Among non-Western immigrant women, only gastric cancer showed increased incidence (IRR 2.21, 95 % CI 1.88–2.60) and mortality (MRR 2.22, 95 % CI 1.83–2.70). Age at immigration did not impact risk levels.Prolonged duration of residence decreased the risk of gastric cancer in non-Western women, whereas in men the risk remained elevated.</div></div><div><h3>Discussion</h3><div>The increased cancer risk among non-Western immigrants may stem from greater exposure to infections such as hepatitis B and C and H. pylori, prevalent in their countries of origin. Cultural adaptation and lifestyle changes, particularly in alcohol and tobacco use, also play a role.</div></div><div><h3>Conclusion</h3><div>Targeted healthcare measures, including early diagnosis and lifestyle interventions, are crucial for reducing cancer risks among non-Western immigrants in Finland. Addressing language and cultural barriers is essential for effective healthcare and for reducing health disparities.</div></div>","PeriodicalId":56322,"journal":{"name":"Cancer Epidemiology","volume":"100 ","pages":"Article 102974"},"PeriodicalIF":2.3,"publicationDate":"2025-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145835371","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ambient air pollution and laryngeal cancer: A systematic review 环境空气污染与喉癌:一项系统综述。
IF 2.3 3区 医学 Q3 ONCOLOGY Pub Date : 2025-12-23 DOI: 10.1016/j.canep.2025.102981
Jasen Soopramanien , Sagar Mittal , Kinjal Jadeja , Lakshya Soni , Samiyah Saghir , Fathima Mannan
Ambient air pollution is a major global health concern, yet its association with laryngeal cancer remains poorly defined. This systematic review aimed to evaluate the relationship between long-term exposure to outdoor air pollutants and incidence of laryngeal cancer. Comprehensive searches of MEDLINE, EMBASE, CENTRAL, and SCOPUS were conducted from inception to 01/06/2024. Eligible studies included observational and ecological designs reporting quantitative associations between ambient pollutants and laryngeal cancer incidence. Study quality, risk of bias, and evidence certainty graded were appraised using the NIH tool, National Toxicology Program framework and GRADE approach respectively. A total of nine studies (4 ecological, 5 cohort) comprising over 7.4 million participants were included. Each pollutant was analysed by a maximum of 3 studies. Nitrogen dioxide (NO₂) demonstrated the most consistent association with laryngeal cancer, with hazard ratios between 1.18 and 1.24 per 10 μg/m³ increase. One large cohort reported a significant relationship between particulate matter ≤ 2.5 μm (PM₂.₅) and laryngeal cancer (HR 1.85; 95 % CI: 1.2–2.85), while findings across other pollutants, including PM₁₀, SO₂, O₃, CO, and NOₓ, were inconsistent. Although data remain limited, emerging evidence suggests that chronic exposure to ambient NO₂ and PM₂.₅ may increase laryngeal cancer risk. Future large-scale prospective cohort studies with standardized exposure metrics and robust confounding control are needed to better characterise this relationship. Natural experiments in regions undergoing major air-quality policy changes can provide valuable evidence on the impact of reducing exposure on laryngeal cancer incidence at a population level.
环境空气污染是一个主要的全球健康问题,但其与喉癌的关系仍不明确。本系统综述旨在评估长期暴露于室外空气污染物与喉癌发病率之间的关系。对MEDLINE、EMBASE、CENTRAL和SCOPUS进行了全面的检索,检索时间从成立到2024年6月1日。符合条件的研究包括观察性和生态学设计,报告了环境污染物与喉癌发病率之间的定量关联。研究质量、偏倚风险和证据确定性分级分别使用NIH工具、国家毒理学计划框架和GRADE方法进行评估。共纳入9项研究(4项生态研究,5项队列研究),参与者超过740万人。每种污染物最多进行3项研究分析。二氧化氮(NO₂)与喉癌的相关性最为一致,风险比为每10 μg/m³ 增加1.18 ~ 1.24。一个大型队列报告了颗粒物质≤ 2.5 μm (PM₂.₅)与喉癌(HR 1.85; 95 % CI: 1.2-2.85)之间的显着关系,而其他污染物的调查结果,包括PM₁₀,SO₂,O₃,CO和NOₓ,则不一致。尽管数据仍然有限,但新出现的证据表明,长期暴露于环境中的NO₂和PM₂。₅可能会增加喉癌的风险。未来的大规模前瞻性队列研究需要标准化的暴露指标和强大的混杂控制来更好地表征这种关系。在空气质量政策发生重大变化的地区进行自然实验,可以为减少接触对人群水平喉癌发病率的影响提供有价值的证据。
{"title":"Ambient air pollution and laryngeal cancer: A systematic review","authors":"Jasen Soopramanien ,&nbsp;Sagar Mittal ,&nbsp;Kinjal Jadeja ,&nbsp;Lakshya Soni ,&nbsp;Samiyah Saghir ,&nbsp;Fathima Mannan","doi":"10.1016/j.canep.2025.102981","DOIUrl":"10.1016/j.canep.2025.102981","url":null,"abstract":"<div><div>Ambient air pollution is a major global health concern, yet its association with laryngeal cancer remains poorly defined. This systematic review aimed to evaluate the relationship between long-term exposure to outdoor air pollutants and incidence of laryngeal cancer. Comprehensive searches of MEDLINE, EMBASE, CENTRAL, and SCOPUS were conducted from inception to 01/06/2024. Eligible studies included observational and ecological designs reporting quantitative associations between ambient pollutants and laryngeal cancer incidence. Study quality, risk of bias, and evidence certainty graded were appraised using the NIH tool, National Toxicology Program framework and GRADE approach respectively. A total of nine studies (4 ecological, 5 cohort) comprising over 7.4 million participants were included. Each pollutant was analysed by a maximum of 3 studies. Nitrogen dioxide (NO₂) demonstrated the most consistent association with laryngeal cancer, with hazard ratios between 1.18 and 1.24 per 10 μg/m³ increase. One large cohort reported a significant relationship between particulate matter ≤ 2.5 μm (PM₂.₅) and laryngeal cancer (HR 1.85; 95 % CI: 1.2–2.85), while findings across other pollutants, including PM₁₀, SO₂, O₃, CO, and NOₓ, were inconsistent. Although data remain limited, emerging evidence suggests that chronic exposure to ambient NO₂ and PM₂.₅ may increase laryngeal cancer risk. Future large-scale prospective cohort studies with standardized exposure metrics and robust confounding control are needed to better characterise this relationship. Natural experiments in regions undergoing major air-quality policy changes can provide valuable evidence on the impact of reducing exposure on laryngeal cancer incidence at a population level.</div></div>","PeriodicalId":56322,"journal":{"name":"Cancer Epidemiology","volume":"100 ","pages":"Article 102981"},"PeriodicalIF":2.3,"publicationDate":"2025-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145829164","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Socioeconomic inequalities in prostate cancer mortality: Response to recent commentary 前列腺癌死亡率的社会经济不平等:对最近评论的回应。
IF 2.3 3区 医学 Q3 ONCOLOGY Pub Date : 2025-12-20 DOI: 10.1016/j.canep.2025.102978
Mohammad Hajizadeh, Grace Johnston
This document is the authors’ response to the received comments for manuscript CANEP-D-25-00363.
本文是作者对CANEP-D-25-00363稿件评论的回复。
{"title":"Socioeconomic inequalities in prostate cancer mortality: Response to recent commentary","authors":"Mohammad Hajizadeh,&nbsp;Grace Johnston","doi":"10.1016/j.canep.2025.102978","DOIUrl":"10.1016/j.canep.2025.102978","url":null,"abstract":"<div><div>This document is the authors’ response to the received comments for manuscript CANEP-D-25-00363.</div></div>","PeriodicalId":56322,"journal":{"name":"Cancer Epidemiology","volume":"100 ","pages":"Article 102978"},"PeriodicalIF":2.3,"publicationDate":"2025-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145806469","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cancer in the oldest old 癌症发生在最老的时候
IF 2.3 3区 医学 Q3 ONCOLOGY Pub Date : 2025-12-18 DOI: 10.1016/j.canep.2025.102980
Charline Jean, Esther Bastiaannet, Melody K. Schiaffino, Sophie Pilleron , Florence Canouï-Poitrine
{"title":"Cancer in the oldest old","authors":"Charline Jean,&nbsp;Esther Bastiaannet,&nbsp;Melody K. Schiaffino,&nbsp;Sophie Pilleron ,&nbsp;Florence Canouï-Poitrine","doi":"10.1016/j.canep.2025.102980","DOIUrl":"10.1016/j.canep.2025.102980","url":null,"abstract":"","PeriodicalId":56322,"journal":{"name":"Cancer Epidemiology","volume":"100 ","pages":"Article 102980"},"PeriodicalIF":2.3,"publicationDate":"2025-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145790779","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of gastrointestinal bleeding on hospital outcomes in hematologic malignancies: A nationwide cross-sectional study 胃肠出血对血液系统恶性肿瘤医院预后的影响:一项全国性的横断面研究。
IF 2.3 3区 医学 Q3 ONCOLOGY Pub Date : 2025-12-18 DOI: 10.1016/j.canep.2025.102975
Pragya Jain , Iqra Qazi , Jacob Thompson , Nency Ganatra , Shivam Patel , Junaid Anwar
Gastrointestinal (GI) bleeding is a frequent cause of hospitalizations and is linked to greater inpatient morbidity, especially among cancer patients. Despite being a recognized complication in patients with hematologic malignancies (HMs), its impact on hospitalization outcomes and healthcare utilization in HM patients is poorly defined. To evaluate the association between GI bleeding and key hospital outcomes, including mortality, length of stay (LOS), and hospitalization costs among adults admitted with HMs, this retrospective cross-sectional study was conducted using the Nationwide Inpatient Sample (NIS) from 2018 to 2022. Multivariable models were fitted using survey-weighted logistic regression for mortality and Poisson regression with a log link for LOS and charges, adjusting for demographic and clinical covariates to calculate adjusted odds ratios (aORs) and adjusted incidence rate ratios (aIRRs), with corresponding 95 % confidence intervals (CIs). Among an estimated 2.9 million weighted hospitalizations with HMs, approximately 13 % were complicated by GI bleeding, which were characterized by higher mortality, longer LOS, and greater healthcare costs. In adjusted models, GI bleeding was associated with higher odds of in-hospital death (aOR: 1.22, 95 % CI: 1.18–1.26) as well as increased LOS (aIRR: 1.36, 95 % CI: 1.34–1.38) and higher hospitalization costs (aIRR: 1.40, 95 % CI: 1.37–1.43). This study's findings indicate that GI bleeding in patients with HMs is an independent predictor of adverse outcomes, including increased mortality and resource utilization. These findings highlight the need for early recognition, risk stratification, and proactive management strategies to mitigate the clinical and economic burden of bleeding in this high-risk population.
胃肠道(GI)出血是住院的常见原因,并与更高的住院发病率有关,特别是在癌症患者中。尽管是恶性血液病(HMs)患者公认的并发症,但其对住院治疗结果和医疗保健利用的影响尚不明确。为了评估胃肠道出血与HMs入院成人的主要医院结局(包括死亡率、住院时间(LOS)和住院费用)之间的关系,本研究采用2018年至2022年全国住院患者样本(NIS)进行了回顾性横断面研究。采用调查加权logistic回归拟合死亡率和泊松回归,对LOS和收费进行对数关联,调整人口统计学和临床协变量,计算调整优势比(aORs)和调整发病率比(aIRRs),相应的置信区间为95% % (ci)。在估计的290万例HMs加权住院患者中,约13% %合并消化道出血,其特点是死亡率更高,LOS时间更长,医疗费用更高。在调整后的模型中,胃肠道出血与更高的院内死亡几率(aOR: 1.22, 95 % CI: 1.18-1.26)、更高的LOS (aIRR: 1.36, 95 % CI: 1.34-1.38)和更高的住院费用(aIRR: 1.40, 95 % CI: 1.37-1.43)相关。本研究结果表明,HMs患者的胃肠道出血是不良结局的独立预测因子,包括死亡率和资源利用率的增加。这些发现强调了早期识别、风险分层和主动管理策略的必要性,以减轻这一高危人群出血的临床和经济负担。
{"title":"Impact of gastrointestinal bleeding on hospital outcomes in hematologic malignancies: A nationwide cross-sectional study","authors":"Pragya Jain ,&nbsp;Iqra Qazi ,&nbsp;Jacob Thompson ,&nbsp;Nency Ganatra ,&nbsp;Shivam Patel ,&nbsp;Junaid Anwar","doi":"10.1016/j.canep.2025.102975","DOIUrl":"10.1016/j.canep.2025.102975","url":null,"abstract":"<div><div>Gastrointestinal (GI) bleeding is a frequent cause of hospitalizations and is linked to greater inpatient morbidity, especially among cancer patients. Despite being a recognized complication in patients with hematologic malignancies (HMs), its impact on hospitalization outcomes and healthcare utilization in HM patients is poorly defined. To evaluate the association between GI bleeding and key hospital outcomes, including mortality, length of stay (LOS), and hospitalization costs among adults admitted with HMs, this retrospective cross-sectional study was conducted using the Nationwide Inpatient Sample (NIS) from 2018 to 2022. Multivariable models were fitted using survey-weighted logistic regression for mortality and Poisson regression with a log link for LOS and charges, adjusting for demographic and clinical covariates to calculate adjusted odds ratios (aORs) and adjusted incidence rate ratios (aIRRs), with corresponding 95 % confidence intervals (CIs). Among an estimated 2.9 million weighted hospitalizations with HMs, approximately 13 % were complicated by GI bleeding, which were characterized by higher mortality, longer LOS, and greater healthcare costs. In adjusted models, GI bleeding was associated with higher odds of in-hospital death (aOR: 1.22, 95 % CI: 1.18–1.26) as well as increased LOS (aIRR: 1.36, 95 % CI: 1.34–1.38) and higher hospitalization costs (aIRR: 1.40, 95 % CI: 1.37–1.43). This study's findings indicate that GI bleeding in patients with HMs is an independent predictor of adverse outcomes, including increased mortality and resource utilization. These findings highlight the need for early recognition, risk stratification, and proactive management strategies to mitigate the clinical and economic burden of bleeding in this high-risk population.</div></div>","PeriodicalId":56322,"journal":{"name":"Cancer Epidemiology","volume":"100 ","pages":"Article 102975"},"PeriodicalIF":2.3,"publicationDate":"2025-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145783846","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Humidifier disinfectant exposure and lung cancer development: A propensity score matching analysis 加湿器消毒剂暴露与肺癌发展:倾向评分匹配分析。
IF 2.3 3区 医学 Q3 ONCOLOGY Pub Date : 2025-12-17 DOI: 10.1016/j.canep.2025.102982
Su Hwan Kim , Sungchan Kang , Sanghee Shin , Jeong-In Hwang , Hyungryul Lim , Dong-Wook Lee , Woojoo Lee , Kang Hee Ha , Youngmee Lee , Taksoo Kim , Hye-Jin Kim , Kyoung-Nam Kim

Background

Although previous animal studies suggest an association between humidifier disinfectant (HD) exposure and lung cancer, epidemiological evidence remains limited.

Methodology

Nationwide data from the National Health Insurance Service and survey data on the HD claimant group were used. A 1:30 propensity score matching was conducted between the HD claimant (n = 4567) and non-exposed groups (n = 153,071). Hazard ratios (HRs) and 95 % confidence intervals (CIs) were estimated using Cox proportional hazards models, incorporating a 4-year latency period.

Results

After matching, the incidence of lung cancer was 2.58 % in the HD claimant group and 0.55 % in the non-exposed group. In the Cox models, the HR for lung cancer in the HD claimant group was 5.71 (95 % CI: 4.70, 6.92) compared with the non-exposed group. Stratified analyses showed an HR of 12.61 (95 % CI: 8.94, 17.79) among women and 4.31 (95 % CI: 3.40, 5.47) among men. The associations also persisted in never-smokers, with an HR of 4.33 (95 % CI: 2.26, 8.30).

Conclusions

Exposure to HDs was associated with an increased risk of lung cancer development. Combined with in vivo and in vitro studies reporting similar associations and plausible mechanisms, the present study supports the potential carcinogenic effects of HDs on lung cancer.
背景:虽然以前的动物研究表明加湿器消毒剂(HD)暴露与肺癌之间存在关联,但流行病学证据仍然有限。方法:使用来自国家健康保险服务的全国数据和HD索赔组的调查数据。在HD索赔者(n = 4567)和非暴露组(n = 153,071)之间进行了1:30倾向评分匹配。使用Cox比例风险模型估计风险比(hr)和95% %置信区间(ci),包括4年潜伏期。结果:匹配后,HD索赔组肺癌发病率为2.58 %,非暴露组肺癌发病率为0.55 %。在Cox模型中,与未暴露组相比,HD索赔组肺癌的HR为5.71(95 % CI: 4.70, 6.92)。分层分析显示,女性的HR为12.61(95 % CI: 8.94, 17.79),男性的HR为4.31(95 % CI: 3.40, 5.47)。这种关联在不吸烟者中也存在,风险比为4.33(95 % CI: 2.26, 8.30)。结论:暴露于HDs与肺癌发展的风险增加有关。结合体内和体外研究报告相似的关联和合理的机制,本研究支持HDs对肺癌的潜在致癌作用。
{"title":"Humidifier disinfectant exposure and lung cancer development: A propensity score matching analysis","authors":"Su Hwan Kim ,&nbsp;Sungchan Kang ,&nbsp;Sanghee Shin ,&nbsp;Jeong-In Hwang ,&nbsp;Hyungryul Lim ,&nbsp;Dong-Wook Lee ,&nbsp;Woojoo Lee ,&nbsp;Kang Hee Ha ,&nbsp;Youngmee Lee ,&nbsp;Taksoo Kim ,&nbsp;Hye-Jin Kim ,&nbsp;Kyoung-Nam Kim","doi":"10.1016/j.canep.2025.102982","DOIUrl":"10.1016/j.canep.2025.102982","url":null,"abstract":"<div><h3>Background</h3><div>Although previous animal studies suggest an association between humidifier disinfectant (HD) exposure and lung cancer, epidemiological evidence remains limited.</div></div><div><h3>Methodology</h3><div>Nationwide data from the National Health Insurance Service and survey data on the HD claimant group were used. A 1:30 propensity score matching was conducted between the HD claimant (<em>n</em> = 4567) and non-exposed groups (<em>n</em> = 153,071). Hazard ratios (HRs) and 95 % confidence intervals (CIs) were estimated using Cox proportional hazards models, incorporating a 4-year latency period.</div></div><div><h3>Results</h3><div>After matching, the incidence of lung cancer was 2.58 % in the HD claimant group and 0.55 % in the non-exposed group. In the Cox models, the HR for lung cancer in the HD claimant group was 5.71 (95 % CI: 4.70, 6.92) compared with the non-exposed group. Stratified analyses showed an HR of 12.61 (95 % CI: 8.94, 17.79) among women and 4.31 (95 % CI: 3.40, 5.47) among men. The associations also persisted in never-smokers, with an HR of 4.33 (95 % CI: 2.26, 8.30).</div></div><div><h3>Conclusions</h3><div>Exposure to HDs was associated with an increased risk of lung cancer development. Combined with in vivo and in vitro studies reporting similar associations and plausible mechanisms, the present study supports the potential carcinogenic effects of HDs on lung cancer.</div></div>","PeriodicalId":56322,"journal":{"name":"Cancer Epidemiology","volume":"100 ","pages":"Article 102982"},"PeriodicalIF":2.3,"publicationDate":"2025-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145783908","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prostate cancer screening: Cancer mortality and opportunistic screening 前列腺癌筛查:癌症死亡率和机会性筛查。
IF 2.3 3区 医学 Q3 ONCOLOGY Pub Date : 2025-12-16 DOI: 10.1016/j.canep.2025.102977
Takeshi Takahashi
{"title":"Prostate cancer screening: Cancer mortality and opportunistic screening","authors":"Takeshi Takahashi","doi":"10.1016/j.canep.2025.102977","DOIUrl":"10.1016/j.canep.2025.102977","url":null,"abstract":"","PeriodicalId":56322,"journal":{"name":"Cancer Epidemiology","volume":"100 ","pages":"Article 102977"},"PeriodicalIF":2.3,"publicationDate":"2025-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145776608","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Cancer Epidemiology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1